These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 16723273)
41. Antistreptolysin O and antideoxyribonuclease B titres in blood donors and in patients with features of nonsuppurative sequelae of group A streptococcus infection in Tanzania. Mhalu FS; Matre R East Afr Med J; 1995 Jan; 72(1):33-6. PubMed ID: 7781553 [TBL] [Abstract][Full Text] [Related]
42. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018 [TBL] [Abstract][Full Text] [Related]
43. HIV-1 and HCV infections among antibody-negative blood donors. Laperche S; Pillonel J; Herve P N Engl J Med; 2004 Nov; 351(21):2232-5; author reply 2232-5. PubMed ID: 15559959 [No Abstract] [Full Text] [Related]
44. Determination of hepatitis C virus RNA in the serum by the Amplicor HCV PCR kit. Prati D; Capelli C; Bosoni P; Mozzi F; Zanella A; Sirchia G Vox Sang; 1994; 67(1):112-4. PubMed ID: 7975444 [No Abstract] [Full Text] [Related]
45. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life. Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599 [TBL] [Abstract][Full Text] [Related]
46. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. Schwarze-Zander C; Blackard JT; Zheng H; Addo MM; Lin W; Robbins GK; Sherman KE; Zdunek D; Hess G; Chung RT; J Infect Dis; 2006 Aug; 194(4):410-9. PubMed ID: 16845623 [TBL] [Abstract][Full Text] [Related]
47. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection. Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844 [TBL] [Abstract][Full Text] [Related]
48. Comparison of the Abbott Realtime HIV-1 and HCV viral load assays with commercial competitor assays. Schutten M Expert Rev Mol Diagn; 2008 Jul; 8(4):369-77. PubMed ID: 18598219 [TBL] [Abstract][Full Text] [Related]
49. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3. Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331 [TBL] [Abstract][Full Text] [Related]
50. Possible compartmentalization of hepatitis C viral replication in the genital tract of HIV-1-coinfected women. Minosse C; Calcaterra S; Abbate I; Selleri M; Zaniratti MS; Capobianchi MR J Infect Dis; 2006 Dec; 194(11):1529-36. PubMed ID: 17083037 [TBL] [Abstract][Full Text] [Related]
51. Genotypic distribution of hepatitis C among hepatitis C and HIV co-infected patients in Brazil. Mendes-Correa MC; Cavalheiro NP; Mello C; Barone AA; Gianini RJ Int J STD AIDS; 2008 Sep; 19(9):595-9. PubMed ID: 18725549 [TBL] [Abstract][Full Text] [Related]
52. Hepatitis C virus reinfection in injection drug users. Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW Hepatology; 2006 Nov; 44(5):1139-45. PubMed ID: 17058216 [TBL] [Abstract][Full Text] [Related]
53. Preliminary data for genotype distribution and epidemiological aspects of hepatitis C virus infection in blood donors from Yucatan, Mexico. GarcĂa-Montalvo BM; Macossay-Castillo M Transfus Med; 2007 Dec; 17(6):488-90. PubMed ID: 18067653 [No Abstract] [Full Text] [Related]
54. HCV positivity rate in the seronegative blood donors in China. Yang Z; Han YX; Jiang JD; Yang Z; Yu YX; Qiu Y Biomed Pharmacother; 2009 May; 63(4):319-20. PubMed ID: 19246175 [No Abstract] [Full Text] [Related]
55. Distribution of hepatitis C virus (HCV) genotypes among HCV infection risk groups in Lebanon. Makhoul NJ; Choueiri MB; Kattar MM; Soweid AM; Shamseddeen W; Estephan HC; Khalife J; Haddad A; Abi Rached A; Zalloua PA J Clin Virol; 2008 Feb; 41(2):166-7. PubMed ID: 18054277 [No Abstract] [Full Text] [Related]
56. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534 [TBL] [Abstract][Full Text] [Related]
57. Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania. Somi GR; Kibuka T; Diallo K; Tuhuma T; Bennett DE; Yang C; Kagoma C; Lyamuya EF; Swai RO; Kassim S Antivir Ther; 2008; 13 Suppl 2():77-82. PubMed ID: 18575194 [TBL] [Abstract][Full Text] [Related]
58. Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus. Bhagat V; Foont JA; Schiff ER; Regev A Liver Transpl; 2008 Jan; 14(1):92-5. PubMed ID: 18161776 [TBL] [Abstract][Full Text] [Related]
59. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. Urbanus AT; van de Laar TJ; Stolte IG; Schinkel J; Heijman T; Coutinho RA; Prins M AIDS; 2009 Jul; 23(12):F1-7. PubMed ID: 19542864 [TBL] [Abstract][Full Text] [Related]
60. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. Tan Y; Wei QH; Chen LJ; Chan PC; Lai WS; He ML; Kung HF; Lee SS PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]